VASARYA THERAPEUTICS, INC.
Camden, United States · Founded 2024
- Headquarters
- Camden, Delaware
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- vasarya.com
About
Vasarya Therapeutics is a clinical-stage biotech developing novel treatments for fibrotic diseases. Their lead compound VSR-H5 targets a cryptic epitope exposed only in fibrotic tissue, enabling site-specific inhibition of disease progression while avoiding systemic toxicity. The company has received NIH SBIR/STTR funding for IPF and liver fibrosis programs.
Summary
VASARYA THERAPEUTICS, INC. is a Biotech company based in Camden, United States, founded in 2024.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vasarya-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/vasarya-therapeutics-inc" alt="VASARYA THERAPEUTICS, INC. on Indexed.vc" width="260" height="76" /></a>